Publication:
Carbamazepine-induced hypogammaglobulinemia

Loading...
Thumbnail Image

relationships.isOrgUnitOf

Program

relationships.isAuthorOf

Author

Ozaras, Nihal

GÖKSÜGÜR, NADİR

Eroglu, Saliha

Tabak, Omur

Canbakan, Billur

Ozaras, Resat

Advisor

Language

Publisher

Journal Title

Journal ISSN

Volume Title

Abstract

Carbamazepine is used to control seizures. Its common side effects are sleep disorders, anorexia, nausea, vomiting, polydipsia, irritability, ataxia, and diplopia. Involvement of the immune system is rare, and few cases of decreased immunoglobulin levels have been reported. We describe a patient with low immunoglobulin levels due to carbamazepine use who presented with recurrent urinary tract infection. Intravenous immunoglobulin was administered, and immunoglobulin levels increased to safer levels after discontinuation of carbamazepine. Previous reports describe severe infection after carbamazepine-induced hypogammaglobulinemia. Therefore, in patients using antiepileptics, particularly carbamazepine, serum immunoglobulin levels should be checked in those with recurrent infections. (C) 2011 British Epilepsy Association. Published by Elsevier Ltd. All rights reserved.

Description

Source

Keywords

Citation

Ozaras N., GÖKSÜGÜR N., Eroglu S., Tabak O., Canbakan B., Ozaras R., -Carbamazepine-induced hypogammaglobulinemia-, SEIZURE-EUROPEAN JOURNAL OF EPILEPSY, cilt.21, ss.229-231, 2012

Endorsement

Review

Supplemented By

Referenced By

2

Views

163

Downloads

View PlumX Details


Sustainable Development Goals